Brand or Proprietary Name Safety Research

Consults and Rebuttals

Failure Mode and Effects Analysis

Gap Analysis

Name Safety Reports / Submission

Nonproprietary (USAN / INN) Name Research

Product Labeling, Packaging and Trade Dress Research

Promotional / Advertising Research

Regulatory / Safety Review of Container and Carton Labels and Packaging

Risk Management Plans

Submission Strategy

USAN / INN / STEM / CLASS Name Development

The Drug Safety Institute (DSI), a subsidiary of Brand Institute, was founded in 2004. DSI is dedicated to improving the safe use of Pharmaceuticals by providing a global, state-of-the-art, research model for proprietary (brand and line extension) and nonproprietary (USAN/INN) nomenclature research. In addition, DSI offers a medication error prevention analysis associated with labeling of pharmaceuticals, biological products and medical devices. DSI also offers various risk management strategies to our clients.

 

---

At DSI our plan is to make the Brand Institute methodology for proprietary and nonproprietary name safety testing reflective of the FDA and other regulatory agencies review processes.